{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:22:55Z","timestamp":1780428175081,"version":"3.54.1"},"reference-count":55,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sulfamethoxazole\u2010trimethoprim (SMX\u2010TMP) is recommended first\u2010line for <jats:italic>Pneumocystis jirovecii<\/jats:italic> pneumonia (PJP) prophylaxis in kidney transplant recipients. In cases of sulfa allergy or intolerance, our center utilizes dapsone 100\u00a0mg once weekly as alternative prophylaxis. As both agents have the potential to cause hematologic abnormalities, we sought to compare hematologic effect profiles of weekly dapsone versus SMX\u2010TMP in kidney transplant recipients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective, single\u2010center, cohort study included kidney transplant recipients who received SMX\u2010TMP or dapsone for PJP prophylaxis. The primary endpoint was the change in hemoglobin from baseline to nadir. Secondary endpoints included hemoglobin and white blood cell (WBC) count at 1, 3, and 6 months posttransplant, time to hemoglobin nadir, neutropenia incidence, and ANC nadir. In addition, we evaluated the incidence of hospital readmission, bacteremia, and PJP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 509 kidney transplant recipients were included (334 SMX\u2010TMP vs. 175 dapsone). Median decrease in hemoglobin (g\/dL) from baseline to nadir was greater in the dapsone group (0 SMX\u2010TMP vs. \u22120.20 dapsone; <jats:italic>p<\/jats:italic> = 0.046). Mean absolute hemoglobin count was lower in the dapsone group at all time points. There was no difference in WBC, ANC nadir, or incidence of neutropenia at any time point between groups. Greater frequencies in readmissions (30.7%\u00a0vs. 55.7%; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001) and bacteremia (3.6%\u00a0vs. 10.8%; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001) were observed in the dapsone arm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Once\u2010weekly dapsone is associated with statistically significant decreases in hemoglobin when compared to SMX\u2010TMP in a kidney transplant cohort, which may be clinically relevant in select patients. Dapsone use may also increase infection risk.\n<jats:boxed-text content-type=\"graphic\" position=\"anchor\"><jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/tid70012-gra-0001-m.png\"><jats:alt-text>image<\/jats:alt-text><\/jats:graphic><\/jats:boxed-text><\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.70012","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:06:44Z","timestamp":1741694804000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety of Once\u2010Weekly Dapsone for <i>Pneumocystis jirovecii<\/i> Pneumonia Prophylaxis in Kidney Transplant Recipients"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0526-2865","authenticated-orcid":false,"given":"Lauren","family":"Schumacher","sequence":"first","affiliation":[{"name":"Department of Pharmacy University of Kentucky HealthCare  Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4423-9971","authenticated-orcid":false,"given":"Olivia","family":"Philippart","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Kentucky HealthCare  Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey","family":"Carr","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Kentucky  Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J (CJ)","family":"Sadler","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Kentucky  Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravanthi","family":"Paluri","sequence":"additional","affiliation":[{"name":"Department of Nephrology Division of Transplant University of Kentucky HealthCare  Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13587"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.38.5.1197"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.38.7.1580"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12457"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13461"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12813"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20106143.2009.02699.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13543"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216378"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/mjt.0000000000001252"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12161"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.07.025"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20106143.2005.01079.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500030207"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17003"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12291"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1526924819855365"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46690"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13921"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882\u2010018\u20101054\u20107"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/514626"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40064\u2010015\u20100816\u2010y"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12968"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.7182\/pit2015153"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399\u20100012.2009.01129.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12201"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9429265"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5775.610"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u201093\u20104\u2010560"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/4.2.429"},{"issue":"1","key":"e_1_2_9_32_1","first-page":"11","article-title":"A Prospective, Randomized, Double\u2010Blind Study of Trimethoprim\u2010Sulfamethoxazole for Prophylaxis of Infection in Renal Transplantation. Side Effects of Trimethoprim\u2010Sulfamethoxazole, Interaction With Cyclosporine","volume":"119","author":"Maki D. G.","year":"1992","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5935.15"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879\u2010019\u20103944\u20100"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551\u20106776\u201028.2.123"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14000"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399\u20100012.2008.00893.x"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2015.00018"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13058"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13634"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24332"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830230102"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/bf01643198"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcw220"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae342"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14067"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.12659\/aot.883901"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14355"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199503163321101"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440020081010"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030\u2010199512000\u201000007"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199301000-00009"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010122\u201010\u2010199505150\u201000004"},{"key":"e_1_2_9_54_1","unstructured":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. National Institutes of Health Centers for Disease Control and Prevention HIV Medicine Association and Infectious Diseases Society of America 2025 accessed October 6 2024 https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-opportunistic-infection."},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700978"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454\u2010199905000\u201000007"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T12:40:49Z","timestamp":1758112849000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.70012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/tid.70012"],"URL":"https:\/\/doi.org\/10.1111\/tid.70012","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"2024-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70012"}}